Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Allegretti AS, Cullaro G, Kwo P, Pyrsopoulos N, et al. OCE-205, a selective V1a receptor mixed agonist-antagonist, for the treatment of hepatorenal syndrome-acute kidney injury: A phase 2 randomized trial. Hepatology 2026 Apr 8. doi: 10.1097/HEP.0000000000001765.
PMID: 41950496


Privacy Policy